Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhiya Yu

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Nature|September 15, 2016
Ionic immune suppression within the tumour microenvironment limits T cell effector functionRobert Eil, Suman K Vodnala, David Clever, et al.
Blood|October 26, 2010
Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapyChristian S Hinrichs, Zachary A Borman, Luca Gattinoni, et al.
Cancer Cell|June 10, 2020
Multi-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive ImmunotherapiesDevikala Gurusamy, Amanda N Henning, Tori N Yamamoto, et al.
The Journal of Clinical Investigation|January 30, 2019
T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapyTori N Yamamoto, Ping-Hsien Lee, Suman K Vodnala, et al.
Science (New York, N.Y.)|March 30, 2019
T cell stemness and dysfunction in tumors are triggered by a common mechanismSuman Kumar Vodnala, Robert Eil, Rigel J Kishton, et al.
Nature Immunology|February 20, 2019
The transcription factor c-Myb regulates CD8<sup>+</sup> T cell stemness and antitumor immunitySanjivan Gautam, Jessica Fioravanti, Wei Zhu, et al.
The Journal of Clinical Investigation|January 6, 2016
The transcription factor BACH2 promotes tumor immunosuppressionRahul Roychoudhuri, Robert L Eil, David Clever, et al.
Science (New York, N.Y.)|December 11, 2020
Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancerSri Krishna, Frank J Lowery, Amy R Copeland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2020
Antigen Experienced T Cells from Peripheral Blood Recognize p53 NeoantigensParisa Malekzadeh, Rami Yossef, Gal Cafri, et al.
The Journal of Experimental Medicine|August 20, 2003
Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cellsWillem W Overwijk, Marc R Theoret, Steven E Finkelstein, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Nature|September 15, 2016
Ionic immune suppression within the tumour microenvironment limits T cell effector functionRobert Eil, Suman K Vodnala, David Clever, et al.
Blood|October 26, 2010
Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapyChristian S Hinrichs, Zachary A Borman, Luca Gattinoni, et al.
Cancer Cell|June 10, 2020
Multi-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive ImmunotherapiesDevikala Gurusamy, Amanda N Henning, Tori N Yamamoto, et al.
The Journal of Clinical Investigation|January 30, 2019
T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapyTori N Yamamoto, Ping-Hsien Lee, Suman K Vodnala, et al.
Science (New York, N.Y.)|March 30, 2019
T cell stemness and dysfunction in tumors are triggered by a common mechanismSuman Kumar Vodnala, Robert Eil, Rigel J Kishton, et al.
Nature Immunology|February 20, 2019
The transcription factor c-Myb regulates CD8<sup>+</sup> T cell stemness and antitumor immunitySanjivan Gautam, Jessica Fioravanti, Wei Zhu, et al.
The Journal of Clinical Investigation|January 6, 2016
The transcription factor BACH2 promotes tumor immunosuppressionRahul Roychoudhuri, Robert L Eil, David Clever, et al.
Science (New York, N.Y.)|December 11, 2020
Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancerSri Krishna, Frank J Lowery, Amy R Copeland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2020
Antigen Experienced T Cells from Peripheral Blood Recognize p53 NeoantigensParisa Malekzadeh, Rami Yossef, Gal Cafri, et al.
The Journal of Experimental Medicine|August 20, 2003
Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cellsWillem W Overwijk, Marc R Theoret, Steven E Finkelstein, et al.
Pageof 9